Dr. Matthew Stringfellow Sanzalone, MD

Dr. Sanzalone practices at Barnes-Jewish West County Hospital in Creve Coeur, Missouri, part of BJC Health.

Dr. Sanzalone's NPI, 1467834820, was assigned on June 22, 2015. Dr. Sanzalone holds Missouri license 2019024502.

Dr. Sanzalone's primary practice is Barnes-Jewish West County Hospital, at 12634 Olive Boulevard, Creve Coeur, MO 63141 in St. Louis County. The practice phone is (314) 996-8000.

Dr. Sanzalone's primary practice is Barnes-Jewish West County Hospital in Creve Coeur, Missouri, part of BJC Health. Dr. Sanzalone is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Sanzalone to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanzalone practices, 7 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Sanzalone's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Sanzalone is licensed in Missouri.

CMS data shows 1,432 Medicare services from Dr. Sanzalone across 17 procedure codes in 2024, for 355 Medicare patients. Medicare paid $85,109 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 355 Medicare patients who saw Dr. Sanzalone in 2024. The largest group is 75 to 84, with 130 patients. 75% of them have arthritis, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanzalone's median patient age at 72, with 64% women.

In 2024, Dr. Sanzalone wrote 2,152 Medicare Part D claims for 376 patients. 98% of them were for generic drugs. CMS names the drug for 2,057 of them, across 27 drugs with 11 or more claims each, at $92,411 in total drug cost. In 2023, CMS named 1,967 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sanzalone for performance year 2024, reported as part of a group. Dr. Sanzalone accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 92 general payments to Dr. Sanzalone from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Abbott Laboratories paid the most, $1,379.